TG Therapeutics, created in 1993 (United States), from 2214 competing brands. The TG Therapeutics brand is owned by TG Therapeutics, a company listed in New York. TG Therapeutics is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
TG Therapeutics
over 5 years*
USD 24.42